Latest U.S. Research Finds COVID-19 Vaccines 54% Effective Against Symptomatic Infection


The first U.S. study assessing the latest COVID-19 vaccines' effectiveness revealed they are 54% effective at preventing symptomatic infections in adults. This evaluation by the Centers for Disease Control and Prevention involved examining COVID-19 test results from 9,000 individuals at CVS and Walgreens pharmacies, comparing the infection rates among those vaccinated with the new shot against those who were not.

Abstract Written By:
Denson Natividad
February 2, 2024

Get updates from Caring Support

We'll keep you updated on all new application updates and features!

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.